Data in the literature for ovarian cancer showed an inverse association between PARP1 and BRCA1 expression, supporting the hypothesis that loss or dysfunction of one crucial DNA repair pathway can be compensated by a “shift toward” and up-regulation of alternate DNA repair mechanisms [29, 40]. The gene discussed is PARP1; the disease is ovarian cancer.